COVID-19 vaccination simulation launched ahead mass inoculation
January 12, 2021 14:39 GMT+700
A mock patient showed his COVID-19 inoculation card during a simulation for COVID-19 vaccination at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). The health ministry has targeted to jab total 181.5 million people and it has so far managed to secure more than 300 million doses of COVID-19 vaccines from Sinovac, Novavax, global vaccine program COVAX Facility, AstraZeneca and Pfizer. ANTARA FOTO/Muhamamad Adimaja/hp/gtm
A health worker measured oxygen saturation level in a patient during a COVID-19 vaccination simulation at a clinic in Cilincing I, Jakarta, Tuesday (January 12, 2021). The simulation aims to prepare health workers to handle many scenarios in the event of mass COVID-19 inoculation launched in January 13, 2021. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A health official at a clinic in Cilincing I, Jakarta, conducted a COVID-19 vaccination simulation on Tuesday (January 12, 2021). Indonesia’s Food and Drugs Monitoring Agency on Monday (January 11, 2021) approved a COVID-19 vaccine developed by China’s Sinovac Biotech for the first mass vaccination program in January. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A mock patient received a vaccine injection during a COVID-19 vaccination simulation held at a clinic in Cilincing I, Jakarta, Tuesday (January 12, 2021). President Joko Widodo will be among the first people to be injected with COVID-19 vaccine in Indonesia on Wednesday (January 13, 2021). ANTARA FOTO/Muhammad Adimaja/hp/gtm
A medical worker, during a simulation at a clinic in Jakarta, Tuesday (January 12, 2021), treated a mock patient suffering an allergic reaction after COVID-19 vaccination. Indonesia will start its first batch of mass vaccination program for health workers in January 13 through February. ANTARA FOTO/Muhammad Adimaja/hp/gtm
Medical workers prepared a COVID-19 vaccine simulation at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). The initial phase of the inoculation will target 1.3 million health workers and 17.4 million public workers nationwide during the first quarter of 2021. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A medical worker checked a vaccine recipient’s information during a COVID-19 vaccination simulation at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). Indonesian government granted a greenlight to the Sinovac's COVID-19 vaccine after interim data from a late-stage human test showed the jabs to be 65.3% effective. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A mock patient showed his COVID-19 inoculation card during a simulation for COVID-19 vaccination at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). The health ministry has targeted to jab total 181.5 million people and it has so far managed to secure more than 300 million doses of COVID-19 vaccines from Sinovac, Novavax, global vaccine program COVAX Facility, AstraZeneca and Pfizer. ANTARA FOTO/Muhamamad Adimaja/hp/gtm
A health worker measured oxygen saturation level in a patient during a COVID-19 vaccination simulation at a clinic in Cilincing I, Jakarta, Tuesday (January 12, 2021). The simulation aims to prepare health workers to handle many scenarios in the event of mass COVID-19 inoculation launched in January 13, 2021. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A health official at a clinic in Cilincing I, Jakarta, conducted a COVID-19 vaccination simulation on Tuesday (January 12, 2021). Indonesia’s Food and Drugs Monitoring Agency on Monday (January 11, 2021) approved a COVID-19 vaccine developed by China’s Sinovac Biotech for the first mass vaccination program in January. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A mock patient received a vaccine injection during a COVID-19 vaccination simulation held at a clinic in Cilincing I, Jakarta, Tuesday (January 12, 2021). President Joko Widodo will be among the first people to be injected with COVID-19 vaccine in Indonesia on Wednesday (January 13, 2021). ANTARA FOTO/Muhammad Adimaja/hp/gtm
A medical worker, during a simulation at a clinic in Jakarta, Tuesday (January 12, 2021), treated a mock patient suffering an allergic reaction after COVID-19 vaccination. Indonesia will start its first batch of mass vaccination program for health workers in January 13 through February. ANTARA FOTO/Muhammad Adimaja/hp/gtm
Medical workers prepared a COVID-19 vaccine simulation at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). The initial phase of the inoculation will target 1.3 million health workers and 17.4 million public workers nationwide during the first quarter of 2021. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A medical worker checked a vaccine recipient’s information during a COVID-19 vaccination simulation at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). Indonesian government granted a greenlight to the Sinovac's COVID-19 vaccine after interim data from a late-stage human test showed the jabs to be 65.3% effective. ANTARA FOTO/Muhammad Adimaja/hp/gtm
A mock patient showed his COVID-19 inoculation card during a simulation for COVID-19 vaccination at a community health center in Cilincing I, Jakarta, Tuesday (January 12, 2021). The health ministry has targeted to jab total 181.5 million people and it has so far managed to secure more than 300 million doses of COVID-19 vaccines from Sinovac, Novavax, global vaccine program COVAX Facility, AstraZeneca and Pfizer. ANTARA FOTO/Muhamamad Adimaja/hp/gtm
